Finance
2024.05.27
Lumosa to Participate the 2024 BIO International Convention
Finance
2024.05.14
Center Lab Group Executive Takes Helm as New Lumosa Chairman to Drive Global Licensing of LT3001 Stroke Candidate
Clinical Enrollment on Track, Data Readout Expected by Year-End
Finance
2024.04.08
Lumosa Partners with Center Lab to Invest in GenEditBio, Targeting Gene Therapy
Finance
2024.01.22
Lumosa Launching LT3001 Phase 2 Trials in Multiple EU Countries
Finance
2023.12.05
Lumosa’s Lead Candidate LT3001 for Acute Ischemic Stroke Approaching Key Milestone, Targeting Unblinding in Late 2024
Finance
2023.11.09
LT1001 Long-Acting Analgesic Injection Licensed in India